A 65-year-old mandeveloped acute renal failure with eosinophilia two weeks after a coronary bypass operation and angiography. Renal biopsy revealed cholesterol crystal embolism (CCE) in glomeruli and arterioles.
Introduction
Renal cholesterol embolic disease is one type of cholesterol crystal embolism (CCE). CCE is characterized by multisystem organ dysfunction due to the occlusion of small to medium-sized arteries by atheromatous plaque deriving from the aorta or large feeder arteries.
Target organs include kidneys, muscle, skin, and retina. In recent years the importance of CCE has increased as the cause of renal failure. However, no effective therapy has been established. We encountered a case of CCE in which renal function was maintained by corticosteroid pulse therapy.
For editorial comment, see p 1 159. According to the clinical and laboratory findings, the recurrence of CCE was suspected and steroid pulse therapy (methyl-prednisolone 250 mg/day for two days) was started.
After repeating pulse therapy once more, renal function was gradually recovered to 3.5 mg/dl serum creatinine. Eosinophilia and his general condition were also improved. During the steroid pulse therapy, the amount of insulin subcutaneous injection was increased to control blood glucose levels; pointed out. This patient also had multiple risk factors for CCE including hypertension, diabetes mellitus and anticoagulation therapy. Clinical symptoms including concurrent ischemic changes of lower extremities were compatible for CCE. These findings strongly suggest that renal CCE which developed in renal sclerotic arteries was the cause of acute renal failure in this case. It is speculated that coronary artery bypass grafting and/or coronary angiography were the cause ofrenal CCE.
Although some reports have indicated the usefulness of pentoxifylline and low density lipoprotein (LDL) apheresis (1, 4), the treatment for CCE has not been established (5). Concerning the steroid therapy, a disagreement exists (6). Several reports showed that some patients with CCE benefited from low-dose corticosteroid therapy (4, 7). Hasegawa et al analyzed several cases that were treated with corticosteroid and recommended the usage of low-dose corticosteroid (0.6 mg/kg/day) (8). In the present case, the initial treatment by low-dose oral steroid seemed to have some limited effects to attenuate the progression of renal failure due to CCE, however it failed to reverse the renal failure. Interestingly, steroid pulse therapy was effective to attenuate the deterioration of renal function. This suggests that a high dose, but not a low dose, of steroid was necessary to attenuate the CCE-induced renal failure in the present case. The effectiveness of steroid pulse therapy in CCE-induced renal failure has been rarely reported before.
Generally, steroid pulse therapy has not been recommended in diabetic patients, however, it is not a contraindication if careful control of blood glucose levels by insulin administration can be achieved.
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